Medical management and sublingual immunotherapy practices in patients with house dust mite-induced respiratory allergy: A retrospective, observational study

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 1, 2012, Pages 193-206

  Trebuchon, Florence ^a   David, M ^b   Demoly, P ^c  

^a Stallergenes SA ^*  (France)

^b Stallergenes SA   (France)

^c HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

House dust mites; Medical management; Observational study; Respiratory allergy; Sublingual immunotherapy

Indexed keywords

HOUSE DUST ALLERGEN;

ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CLINICAL EVALUATION; CLINICAL PRACTICE; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; FEMALE; HOUSE DUST ALLERGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHUMAN; OBSERVATIONAL STUDY; PATIENT SATISFACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBLINGUAL IMMUNOTHERAPY; ADOLESCENT; ALLERGIC ASTHMA; CHILD; DRUG EFFICACY; DRUG SAFETY; FRANCE; MAINTENANCE THERAPY; PATIENT COMPLIANCE; TREATMENT DURATION;

EID: 84861462673     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500122     Document Type: Article

References (25)

1. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108:S147-S334.
2. Bousquet P, Bousquet-Rouanet L, Minh H, Urbinelli R, Allaert F, Demoly P. ARIA (Allergic Rhinitis and its Impact on Asthma) classification of allergic rhinitis severity in clinical practice in France. Int Arch Allergy Immunol. 2007; 143:163-9. (Pubitemid 46918457)
3. Canonica GW, Bousquet J, Casale T, et al. Sublingual Immunotherapy: World Allergy Organization Position Paper 2009. Allergy 2009; 64:1-59.
4. Compalati E, Passalacqua G, Bonini M, Canonica GW. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis. Allergy 2009; 64:1570-79.
5. Didier A, Chartier A, Démonet G. Immunothérapie sublinguale: pour quel profil de patients en pratique? Analyse intermédiaire d'Odissee (observatoire de l'indication, du choix de prise en charge par immunothérapie spécifique sublinguale ainsi que de l'adhésion et de l'observance au traitement chez les patients souffrant d'allergie respiratoire [rhinite et/ou conjonctivite et/ou asthme allergique]). Rev Fr Allergol 2010; 50:426-33.
6. Demoly P, Allaert F-A, Lecasble M, PRAGMA. ERASM, a pharmacoepidemiologic survey on management of intermittent allergic rhinitis in every day general medical practice in France. Allergy 2002; 57:546-54. (Pubitemid 34539130)
7. Migueres M, Fontaine J-F, Haddad T, Grosclaude M, Saint-Martin F, Bern David D, Crestani B. Characteristics of patients with respiratory allergy in France and factors influencing immunotherapy prescription: a prospective observational study (REALIS). Int J Immunopathol Pharmacol 2011; 24:387-400.
8. Didier A, Melac M, Montagut A, Lheritier-Barrand M, Tabar A, Worm M. Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy. Allergy 2009; 64:166-71.
9. Pham Thi N, Muller D, Thillay A. House dust mite sublingual immunotherapy: results from a national survey. La Lettre du Pneumologue 2009; XII:100-104.
10. Didier A, Malling H-M, Worm M, et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007; 120:1338-45. (Pubitemid 350225683)
11. Ghunaim N, Wickman M, Almquist C, Soderstrom L, Ahlstedt A, van Hage M. Sensitization to different pollens and allergic disease in 4-year-old Swedish children. Clin Exp Allergy 2006; 36:722-7. (Pubitemid 43972967)
12. Nyembue TD, Vinck AS, Corvers K, Bruninx L, Hellings PW, Jorissen M. Sensitization to common aeroallergens in patients at an outpatient ENT clinic. B-ENT 2011; 7:79-85.
13. de Bot CM, Moed H, Berger MY, Röder E, de Groot H, de Jongste JC, van Wijk RG, van der Wouden JC. Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: study design and recruitment. BMC Fam Pract 2008; 9:59.
14. Calamita Z, Saconato H, Pela AB, Atallah AN. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method. Allergy 2006; 61:1162-72. (Pubitemid 44326350)
15. Vervloet D, Penaud A, Rassouk H, Senft M, Arnauld A, Boutin C, Charpin J. Altitude and House Dust Mites. J Allergy Clin Immunol 1982; 69:290-96. (Pubitemid 12192644)
16. Dahl R, Kapp A, Colombo G, de Monchy JGR, Rak S, Emminger W, Rivas MF, Ribel M, Durham SR. Efficacy and safety of sublingual immunotherapy with grass pollen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006; 118:434-40. (Pubitemid 44160721)
17. Marogna M, Spadolini I, Massolo A, Canonica GW, Passalacqua G. Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more. Allergy 2004; 59:1205-10. (Pubitemid 39389476)
18. Vita D, Caminiti L, Ruggeri P, Pajno GB. Immunotherapy: adherence based on timing and monitoring control visits. Allergy 2010; 65:668-9.
19. Incorvaia C, Mauro M, Ridolo E, Puccinelli P, Liuzzo M, Scurati S, Frati F. Patient's compliance with allergen immunotherapy. Patient Prefer Adherence 2008; 2:247-51
20. Passalacqua G, Musarra A, Pecora S, et al. Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children (EASY project: evaluation of a novel SLIT formulation during a year). Pediatr Allergy Immunol 2007; 18:58-62. (Pubitemid 46232284)
21. Tabar AI, Arroabarren E, Echechipía S, García BE, Martin S, Alvarez-Puebla MJ. Three years of specific immunotherapy may be sufficient in house dust mite respiratory allergy. J Allergy Clin Immunol 2011; 127:57-63.
22. Hassan E. Recall bias can be a threat to retrospective and prospective research designs. Internet J Epidemiol 2006; 2:4-4.
23. Chang H, Han DH, Mo JH, Kim JW, Kim DY, Lee CH, Min YG, Rhee CS. Early compliance and efficacy of sublingual immunotherapy in patients with allergic rhinitis for house dust mites. Clin Exp Otorhinolaryngol 2009; 2:136-40.
24. Horak F, Jaeger, S, Worm, M, Melac M, Didier A. Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment. Clin Exp Allergy 2009; 39:394-400.
25. Cox LS, Larenas-Linnemann D, Nolte H, Weldon D, Finegold I, Nelson HS. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 2006; 117:1021-35. (Pubitemid 44308083)